A detailed history of Principal Securities, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Principal Securities, Inc. holds 4,299 shares of VRTX stock, worth $2.22 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,299
Previous 4,073 5.55%
Holding current value
$2.22 Million
Previous $1.91 Billion 4.73%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$460.0 - $505.78 $103,960 - $114,306
226 Added 5.55%
4,299 $2 Billion
Q2 2024

Jul 31, 2024

BUY
$392.81 - $485.53 $442,696 - $547,192
1,127 Added 38.26%
4,073 $1.91 Billion
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $237,275 - $259,618
582 Added 24.62%
2,946 $1.23 Billion
Q4 2023

Feb 07, 2024

BUY
$343.0 - $410.68 $810,852 - $970,847
2,364 New
2,364 $962 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.